ArticleJournal of cellular and molecular medicine2021

Generation of 'designer erythroblasts' lacking one or more blood group systems from CRISPR/Cas9 gene-edited human-induced pluripotent stem cells.

Priyanka Pandey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.